We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Disease Control and Prevention (CDC) will evaluate Novavax's pandemic influenza vaccine, including conducting preclinical tests on a live strain of H5N1 bird flu virus, the company said.
Mayne Pharma announced it has received marketing approval for its generic oxaliplatin product in Germany, which is one of the largest oxaliplatin markets, according to the company.
More than 320,000 young children in Lebanon will receive the first round of polio vaccinations in a UN-backed immunization campaign started following the severe disruption of routine health services caused by the conflict between Israel and Hezbollah.
Merck announced it has entered into a definitive agreement under which Merck will acquire Sirna Therapeutics, a U.S.-based biotechnology company and a leader in developing a new class of medicines based on RNA interference (RNAi) technology.
Up to $50 billion is spent every year on pharmaceutical products in a market so large that it is extremely vulnerable to corruption, according to the World Health Organization (WHO).
Baxter announced that Japan's Ministry of Health, Labor and Welfare has approved Advate (rurioctocog alfa, recombinant, plasma/albumin free method) as a replacement therapy indicated for blood coagulation and to reduce the tendency to bleed for people with factor VIII deficiency (hemophilia A).
Dong-A Pharmaceutical has announced that Zydena, its drug to treat erectile dysfunction (ED), will be distributed in Saudi Arabia, Oman, Bahrain, Kuwait, the United Arab Emirates and Qatar under a supply and distribution agreement with Saudi Chevron Petrochemical.
U.S. researchers have reported results of a study that substantially alters the existing understanding of how the influenza virus evolves and that could have important implications for predicting which strains should be used for flu vaccine.
The European Patent Office (EPO) issued an opinion upholding Pfizer's Lipitor patent, siding with the company in a patent infringement case filed by generic drugmaker Ranbaxy.